Recent meetings
No recorded meetings with EU commissioners.
Mission & Goals
Our vision is to ensure that in silico medicine is fully realised, universally adopted, and effectively used both in research and clinic. We act as catalysts to bring together a variety of different stakeholders (policy makers, science funding bodies, regulators, clinical organisations and industry) in order to maximise the benefit of VPH approaches for the healthcare industry and for the public good. To achieve this goal, we: 1. Provide a single voice for all its members 2. Ensure that VPH related research receives all over the world an adequate level of funding 3. Act as a think-tank to advise and support governmental and non-governmental institutions on research & technology development programmes and initiatives on in silico medicine 4. Provide a platform for the exchange of ideas, challenges, solutions and experience among stakeholders 5. Sustain the dissemination of VPH research through a number of activities (our bi-annual VPH Conference, Summer School, webinars, newsletter)
EU Legislative Interests
EMA Draft Guidance on Mechanistic Models in Model-Informed Drug Development; European Health Data Space implementation guidelines; EU regulations on medical devices (Regulation 2017/745) In vitro diagnostic devices (Regulation 2017/746) Integration of artificial intelligence (AI) throughout the lifecycle of medicinal products. Medical Devices Regulation (EU) 2017/745 - MDR - DNV
Communication Activities
- Sent our contribution to the MDR Revision Proposals to the European Commission
Interests Represented
Does not represent commercial interests
Member Of
Avicenna Alliance https://www.avicenna-alliance.com/
Organisation Members
https://vph-society.org/who-we-are/governance/#board https://vph-society.org/who-we-are/our-members/